Patents by Inventor Erick Giang

Erick Giang has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20230034467
    Abstract: The present invention provides novel engineered HCV E2 polypeptide immunogens and related vaccine compositions that display the engineered E2 polypeptides. The invention also provides methods of using such immunogens and vaccine compositions in various therapeutic applications, e.g., for preventing or treating HCV infections.
    Type: Application
    Filed: December 17, 2021
    Publication date: February 2, 2023
    Inventors: Linling He, Jiang Zhu, Erick Giang, Mansun Law, Ian Wilson, Netanel Tzarum
  • Patent number: 11008368
    Abstract: The present invention provides novel engineered HCV E2 polypeptide immunogens and related vaccine compositions that display the engineered E2 polypeptides. The invention also provides methods of using such immunogens and vaccine compositions in various therapeutic applications, e.g., for preventing or treating HCV infections.
    Type: Grant
    Filed: July 24, 2020
    Date of Patent: May 18, 2021
    Assignee: THE SCRIPPS RESEARCH INSTITUTE
    Inventors: Linling He, Jiang Zhu, Erick Giang, Mansun Law, Ian Wilson, Netanel Tzarum
  • Publication number: 20210024585
    Abstract: The present invention provides novel engineered HCV E2 polypeptide immunogens and related vaccine compositions that display the engineered E2 polypeptides. The invention also provides methods of using such immunogens and vaccine compositions in various therapeutic applications, e.g., for preventing or treating HCV infections.
    Type: Application
    Filed: July 24, 2020
    Publication date: January 28, 2021
    Inventors: Linling He, Jiang Zhu, Erick Giang, Mansun Law, Ian Wilson, Netanel Tzarum